Detection of meticillin-resistant Staphylococcus aureus and Panton-Valentine leukocidin directly from clinical samples and the development of a multiplex assay using real-time polymerase chain reaction

  • L. Renwick
  • A. Hardie
  • E. K. Girvan
  • M. Smith
  • G. Leadbetter
  • E. Claas
  • D. Morrison
  • A. P. Gibb
  • J. Dave
  • K. E. Templeton
Article

Abstract

Meticillin-resistant Staphylococcus aureus (MRSA) is a major pathogen responsible for significant numbers of healthcare-associated infections and isolates containing Panton-Valentine leukocidin (PVL) that cause severe skin infections are emerging as a serious problem. The rapid detection of MRSA would be an invaluable tool in a diagnostic laboratory. The aim of this study is to develop real-time polymerase chain reaction (PCR) assays for the detection of MRSA and PVL directly from clinical samples, and then combining these assays. Individual assays for MRSA (SCCmec) and PVL (lukF and lukS) were optimised and evaluated with screening and wound swabs, respectively. MRSA- and PVL-positive isolates were detected by the assays with an analytical sensitivity of 100 cfu per reaction. No other bacterial species were amplified. Fifty of 402 (12.4%) nasal swabs were positive by culture and PCR. Four of the 402 (1.0%) swabs were PCR-positive/culture-negative. Three of the 402 (0.7%) swabs were PCR-negative/culture-positive. The sensitivity of the MRSA assay is 95% and the specificity is 99% using conventional culture as the gold standard. Five of 240 wound swabs (2.1%) were positive for PVL. Three of the PVL-positive swabs were meticillin-sensitive Staphylococcus aureus (MSSA) and two were MRSA. The MRSA assay is a powerful and sensitive diagnostic tool, giving rapid results and could allow more timely treatment and infection control decisions to be taken. It can also, when combined with the PVL assay, provide valuable epidemiological information.

References

  1. 1.
    Jevons MP (1961) “Celbenin”-resistant staphylococci. Br Med J 1:124–125CrossRefGoogle Scholar
  2. 2.
    Stefani S, Varaldo PE (2003) Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 9:1179–1186PubMedCrossRefGoogle Scholar
  3. 3.
    Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H, Mallaghan C, Tucker DR (2006) Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 635:S1–S44CrossRefGoogle Scholar
  4. 4.
    Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 57:589–608PubMedCrossRefGoogle Scholar
  5. 5.
    Saïd-Salim B, Mathema B, Braughton K, Davis S, Sinsimer D, Eisner W, Likhoshvay Y, Deleo FR, Kreisworth BN (2005) Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 43:3373–3379PubMedCrossRefGoogle Scholar
  6. 6.
    Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984PubMedGoogle Scholar
  7. 7.
    Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piémont Y, Brousse N, Floret D, Etienne J (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753–759PubMedCrossRefGoogle Scholar
  8. 8.
    Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666–674PubMedCrossRefGoogle Scholar
  9. 9.
    Prévost G, Mourey L, Colin DA, Menestrina G (2001) Staphylococcal pore-forming toxins. Curr Top Microbiol Immunol 257:53–83PubMedGoogle Scholar
  10. 10.
    Prévost G, Cribier B, Couppié P, Petiau P, Supersac G, Finck-Barbançon V, Monteil H, Piémont Y (1995) Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun 63:4121–4129PubMedGoogle Scholar
  11. 11.
    Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK (2004) Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 39:971–979PubMedCrossRefGoogle Scholar
  12. 12.
    Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B, Boo T, McAllister S, Anderson J, Jensen B, Dodson D, Lonsway D, McDougal LK, Arduino M, Fraser VJ, Killgore G, Tenover FC, Cody S, Jernigan DB (2005) A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352:468–475PubMedCrossRefGoogle Scholar
  13. 13.
    Davis SL, Perri MB, Donabedian SM, Manierski C, Singh A, Vager D, Haque NZ, Spiers K, Muder RR, Robinson-Dunn B, Hayden MK, Zervos MJ (2007) Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Micro 45:1705–1711CrossRefGoogle Scholar
  14. 14.
    Etienne J (2005) Panton-Valentine leukocidin: a marker of severity for Staphylococcus aureus infection? Clin Infect Dis 41:591–593PubMedCrossRefGoogle Scholar
  15. 15.
    Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hansel NN, Perl T, Ticehurst JR, Carroll K, Thomas DL, Nuermberger E, Bartlett JG (2005) Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40:100–107PubMedCrossRefGoogle Scholar
  16. 16.
    Brown DFJ, Edwards DI, Hawkey PM, Morrison D, Ridgway GL, Towner KJ, Wren MWD (2005) Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56:1000–1018PubMedCrossRefGoogle Scholar
  17. 17.
    Stoakes L, Reyes R, Daniel J, Lennox G, John MA, Lannigan R, Hussain Z (2006) Prospective comparison of a new chromogenic medium, MRSAselect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44:637–639PubMedCrossRefGoogle Scholar
  18. 18.
    Melles DC, Gorkink RF, Boelens HA, Snijders SV, Peeters JK, Moorhouse MJ, van der Spek PJ, van Leeuwen WB, Simons G, Verbrugh HA, van Belkum A (2004) Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest 114:1732–1740PubMedGoogle Scholar
  19. 19.
    Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, van der Noordaa J (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28:495–503PubMedGoogle Scholar
  20. 20.
    Loens K, Bergs K, Ursi D, Goossens H, Ieven M (2007) Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens. J Clin Microbiol 45:421–425PubMedCrossRefGoogle Scholar
  21. 21.
    Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, Gagnon F, Truchon K, Bastien M, Picard FJ, van Belkum A, Ouellette M, Roy PH, Bergeron MG (2004) New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol 42:1875–1884PubMedCrossRefGoogle Scholar
  22. 22.
    Simmonds P, Smith DB (1999) Structural constraints on RNA virus evolution. J Virol 73:5787–5794PubMedGoogle Scholar
  23. 23.
    McDonald RR, Antonishyn NA, Hansen T, Snook LA, Nagle E, Mulvey MR, Levett PN, Horsman GB (2005) Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43:6147–6149PubMedCrossRefGoogle Scholar
  24. 24.
    Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128–1132PubMedCrossRefGoogle Scholar
  25. 25.
    Cunningham R, Jenks P, Northwood J, Wallis M, Ferguson S, Hunt S (2007) Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect 65:24–28PubMedCrossRefGoogle Scholar
  26. 26.
    Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM (2005) Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 43:2384–2390PubMedCrossRefGoogle Scholar
  27. 27.
    El-Zimaity D, Dawson SJ, Barrett S, Moseley E (2004) Preoperative screening of elective orthopaedic patients for MRSA. J Hosp Infect 56:164–165PubMedCrossRefGoogle Scholar
  28. 28.
    Malde DJ, Abidia A, McCollum C, Welch M (2006) The success of routine MRSA screening in vascular surgery: a nine year review. Int Angiol 25:204–208PubMedGoogle Scholar
  29. 29.
    Niesters HGM (2001) Quantitation of viral load using real-time amplification techniques. Methods 25:419–429PubMedCrossRefGoogle Scholar
  30. 30.
    Niesters HGM (2004) Molecular and diagnostic clinical virology in real time. Clin Microbiol Infect 10:5–11PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • L. Renwick
    • 1
  • A. Hardie
    • 1
  • E. K. Girvan
    • 2
  • M. Smith
    • 1
  • G. Leadbetter
    • 1
  • E. Claas
    • 3
  • D. Morrison
    • 2
  • A. P. Gibb
    • 1
  • J. Dave
    • 1
  • K. E. Templeton
    • 1
  1. 1.Department of MicrobiologyRoyal Infirmary of EdinburghEdinburghUK
  2. 2.Scottish MRSA Reference Laboratory, Department of MicrobiologyStobhill HospitalGlasgowUK
  3. 3.Department of Medical Microbiology, Center of Infectious DiseasesLeiden University Medical CenterLeidenThe Netherlands

Personalised recommendations